Daiwa Securities Group’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4K | Hold |
1,151
| – | – | ﹤0.01% | 1161 |
|
|
2025
Q1 | $3K | Hold |
1,151
| – | – | ﹤0.01% | 1158 |
|
|
2024
Q4 | $3K | Hold |
1,151
| – | – | ﹤0.01% | 1184 |
|
|
2024
Q3 | $3K | Hold |
1,151
| – | – | ﹤0.01% | 1193 |
|
|
2024
Q2 | $3K | Hold |
1,151
| – | – | ﹤0.01% | 1213 |
|
|
2024
Q1 | $5K | Hold |
1,151
| – | – | ﹤0.01% | 1193 |
|
|
2023
Q4 | $7K | Hold |
1,151
| – | – | ﹤0.01% | 1175 |
|
|
2023
Q3 | $5K | Hold |
1,151
| – | – | ﹤0.01% | 1145 |
|
|
2023
Q2 | $7K | Hold |
1,151
| – | – | ﹤0.01% | 1145 |
|
|
2023
Q1 | $9K | Hold |
1,151
| – | – | ﹤0.01% | 1104 |
|
|
2022
Q4 | $12K | Buy |
1,151
+91
| +9% | +$949 | ﹤0.01% | 1098 |
|
|
2022
Q3 | $10K | Hold |
1,060
| – | – | ﹤0.01% | 1117 |
|
|
2022
Q2 | $11K | Buy |
1,060
+238
| +29% | +$2.47K | ﹤0.01% | 1126 |
|
|
2022
Q1 | $8K | Hold |
822
| – | – | ﹤0.01% | 1140 |
|
|
2021
Q4 | $12K | Buy |
+822
| New | +$12K | ﹤0.01% | 1132 |
|